Immunomodulatory Therapy for the Management of Loiasis
- PMID: 33326992
- DOI: 10.1093/cid/ciaa1367
Immunomodulatory Therapy for the Management of Loiasis
Keywords: IgE; IL-5; adverse reactions; diethylcarbamazine (DEC); immune modulation; loiasis; reslizumab; therapy.
Comment on
-
A Randomized, Placebo-controlled, Double-blind Pilot Study of Single-dose Humanized Anti-IL5 Antibody (Reslizumab) for the Reduction of Eosinophilia Following Diethylcarbamazine Treatment of Loa loa Infection.Clin Infect Dis. 2021 Oct 5;73(7):e1624-e1631. doi: 10.1093/cid/ciaa1365. Clin Infect Dis. 2021. PMID: 32910141 Free PMC article. Clinical Trial.
Similar articles
-
A treatment for loiasis.Nurs Times. 1999 Aug 18-24;95(33):50-1. Nurs Times. 1999. PMID: 10614420 No abstract available.
-
A Randomized, Placebo-controlled, Double-blind Pilot Study of Single-dose Humanized Anti-IL5 Antibody (Reslizumab) for the Reduction of Eosinophilia Following Diethylcarbamazine Treatment of Loa loa Infection.Clin Infect Dis. 2021 Oct 5;73(7):e1624-e1631. doi: 10.1093/cid/ciaa1365. Clin Infect Dis. 2021. PMID: 32910141 Free PMC article. Clinical Trial.
-
Posttreatment Reactions After Single-Dose Diethylcarbamazine or Ivermectin in Subjects With Loa loa Infection.Clin Infect Dis. 2017 Apr 15;64(8):1017-1025. doi: 10.1093/cid/cix016. Clin Infect Dis. 2017. PMID: 28329346 Free PMC article. Clinical Trial.
-
Loiasis.Ann Trop Med Parasitol. 2006 Dec;100(8):715-31. doi: 10.1179/136485906X112194. Ann Trop Med Parasitol. 2006. PMID: 17227650 Review.
-
Loa loa-does it deserve to be neglected?Lancet Infect Dis. 2014 Apr;14(4):353-7. doi: 10.1016/S1473-3099(13)70263-9. Epub 2013 Dec 12. Lancet Infect Dis. 2014. PMID: 24332895 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials